CXCL14 and hepatocellular carcinoma: A case-control study involved with 361 HBV-related HCC cases and 407 healthy controls also supports our finding, it has been revealed that the polymorphism in CXCL14 was associated with the HCC progression, suggesting that CXCL14 might alter the disease development by inhibiting tumor growth [28].